Liang W - Search Results

1

Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem-Like Cells In Vivo.

Wang D, Li W, Zhao R, Chen L, Liu N, Tian Y, Zhao H, Xie M, Lu F, Fang Q, Liang W, Yin F, Li Z. Wang D, et al. Among authors: liang w. Cancer Res. 2019 Apr 15;79(8):1769-1783. doi: 10.1158/0008-5472.CAN-18-1421. Epub 2019 Mar 6. Cancer Res. 2019. PMID: 30842103

2

In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell.

Hu K, Yin F, Yu M, Sun C, Li J, Liang Y, Li W, Xie M, Lao Y, Liang W, Li ZG. Hu K, et al. Among authors: liang w, liang y. Theranostics. 2017 Oct 13;7(18):4566-4576. doi: 10.7150/thno.19840. eCollection 2017. Theranostics. 2017. PMID: 29158845 Free PMC article.

3

Erratum: In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell: Erratum.

Hu K, Yin F, Yu M, Sun C, Li J, Liang Y, Li W, Xie M, Lao Y, Liang W, Li ZG. Hu K, et al. Among authors: liang w, liang y. Theranostics. 2018 Nov 10;8(20):5660-5661. doi: 10.7150/thno.31152. eCollection 2018. Theranostics. 2018. PMID: 30555571 Free PMC article.

4

LINC00311 promotes cancer stem-like properties by targeting miR-330-5p/TLR4 pathway in human papillary thyroid cancer.

Gao Y, Wang F, Zhang L, Kang M, Zhu L, Xu L, Liang W, Zhang W. Gao Y, et al. Among authors: liang w. Cancer Med. 2020 Feb;9(4):1515-1528. doi: 10.1002/cam4.2815. Epub 2020 Jan 2. Cancer Med. 2020. Retraction in: Cancer Med. 2023 May;12(9):11041. doi: 10.1002/cam4.5823 PMID: 31894666 Free PMC article. Retracted.

5

5-Aza-2'-deoxycytidine increases the sensitivity of human bone marrow mesenchymal stem cells to chemotherapeutic agents by demethylation of p73.

Liang W, Xia H, Li J, Chunhua Zhao R. Liang W, et al. J Pediatr Hematol Oncol. 2012 Mar;34(2):108-15. doi: 10.1097/MPH.0b013e31823e0a87. J Pediatr Hematol Oncol. 2012. PMID: 22278203

6

Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agents.

Liang W, Xia H, Li J, Zhao RC. Liang W, et al. Cytotechnology. 2011 Oct;63(5):523-30. doi: 10.1007/s10616-011-9374-5. Epub 2011 Jul 15. Cytotechnology. 2011. PMID: 21761127 Free PMC article.

7

TAp63α mediates chemotherapeutic agent-induced apoptosis in human bone marrow mesenchymal stem cells.

Lu C, Lu S, Liang W, Li J, Dou X, Bian C, Shi D, Liao L, Zhao RC. Lu C, et al. Among authors: liang w. Stem Cells Dev. 2011 Aug;20(8):1319-26. doi: 10.1089/scd.2010.0329. Epub 2011 Feb 24. Stem Cells Dev. 2011. PMID: 21142794

8

Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population.

Zhang B, Liu R, Shi D, Liu X, Chen Y, Dou X, Zhu X, Lu C, Liang W, Liao L, Zenke M, Zhao RC. Zhang B, et al. Among authors: liang w. Blood. 2009 Jan 1;113(1):46-57. doi: 10.1182/blood-2008-04-154138. Epub 2008 Oct 2. Blood. 2009. PMID: 18832657 Free article.

9

p73alpha regulates the sensitivity of bone marrow mesenchymal stem cells to DNA damage agents.

Liang W, Lu C, Li J, Yin JQ, Zhao RC. Liang W, et al. Toxicology. 2010 Mar 30;270(1):49-56. doi: 10.1016/j.tox.2010.01.011. Epub 2010 Jan 25. Toxicology. 2010. PMID: 20100536

10

Self-Adaptive Nanocarriers Overcome Multiple Physiological Barriers to Boosting Chemotherapy of Orthotopic Pancreatic Cancer.

Ding M, Zong Q, Zhang D, Ullah I, Zhang X, Liang W, Li X, Bulatov E, Yuan Y. Ding M, et al. Among authors: liang w. ACS Nano. 2024 Dec 28. doi: 10.1021/acsnano.4c11514. Online ahead of print. ACS Nano. 2024. PMID: 39731749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,873 results

Search Page

Filters